Cardurion Pharmaceuticals
Boston
About Cardurion Pharmaceuticals
Cardurion Pharmaceuticals is a Boston-based biotechnology company focused on developing novel therapeutics for the treatment of heart failure and other cardiovascular diseases. The company is advancing groundbreaking clinical programs targeting PDE9 and CaMKII inhibition, leveraging its expertise in cardiovascular signaling pathways to address unmet patient needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $603.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2024)
- Website: cardurion.com
- Phone: 617-996-1433
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cardurion-pharmaceuticals-83049 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.